An Ultrasound Device Production Facility Will Be Established in Turkey
During his visit to South Korea, Health Minister Kemal Memişoğlu visited Samsung Medison to evaluate the ultrasound device production facility to be established in Turkey and technology transfer processes, and also conducted inspections at IFEZ and Celltrion.
Health Minister Kemal Memişoğlu visited Samsung Medison, one of the leading organizations in medical imaging technologies, during his official visit to South Korea. Evaluating artificial intelligence-supported ultrasound systems and production processes within the scope of ongoing cooperation on-site, Memişoğlu noted that with the production facility to be established in Turkey, ultrasound devices will be produced with a domestic production rate of at least 71 percent.
Within the framework of his visit to South Korea, Health Minister Kemal Memişoğlu visited Samsung Medison and discussed artificial intelligence-supported ultrasound systems and technology transfer processes. Stating that a significant stage has been reached in ultrasound devices, the production of which was initiated last year through technology transfer, Memişoğlu expressed that with the facility to be established, devices ranging from monitors to probes, and software to hardware, will be manufactured with at least a 71 percent domestic production rate.
Minister Memişoğlu also visited IFEZ, one of the world's largest biotechnology, pharmaceutical production, and health technology centers, and evaluated innovative initiatives and technology-focused investments. Visiting Celltrion, a company operating in the biopharmaceutical field, Memişoğlu received information on studies aimed at the development and production of biological drugs and discussed potential cooperation opportunities.